We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+6.04%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$45.2B
AUM Growth
+$7.19B
(+19%)
Cap. Flow
+$5.18B
Cap. Flow
% of AUM
11.47%
Top 10 Holdings %
Top 10 Hldgs %
25.47%
Holding
2,621
New
399
Increased
1,662
Reduced
366
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$250M |
| 3 |
Microsoft
MSFT
|
+$197M |
| 4 |
NVIDIA
NVDA
|
+$185M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$64M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$29.1M |
| 3 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$26M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$21.3M |
| 5 |
AMK
AssetMark Financial Holdings, Inc.
AMK
|
+$20.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.22% |
| 2 | Financials | 7.54% |
| 3 | Healthcare | 7.44% |
| 4 | Consumer Staples | 5.34% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
2476
DELISTED
Verve Therapeutics
VERV
| $53.2K | ﹤0.01% |
+10,995
| New | +$63.9K |
|
|
VRN
2477
DELISTED
Veren
VRN
| $52K | ﹤0.01% |
26,036
+5,034
| +24% | +$36K |
|
2478
8x8 Inc
EGHT
$258M
| $51.5K | ﹤0.01% |
25,256
+8,254
| +49% | +$18.2K |
|
2479
MacroGenics
MGNX
$240M
| $51.5K | ﹤0.01% |
+15,647
| New | +$61K |
|
2480
Planet Labs
PL
$6.93B
| $46.6K | ﹤0.01% |
+20,904
| New | +$46.4K |
|
|
BLUE
2481
DELISTED
bluebird bio
BLUE
| $46.6K | ﹤0.01% |
4,485
+361
| +9% | +$6K |
|
2482
Coherus Oncology
CHRS
$221M
| $46.4K | ﹤0.01% |
+44,577
| New | +$61.1K |
|
2483
TRX Gold Corp
TRX
$253M
| $46K | ﹤0.01% |
117,371
| – | – |
|
2484
Kodiak Sciences
KOD
$2.58B
| $43.7K | ﹤0.01% |
+16,759
| New | +$44.5K |
|
2485
Xeris Biopharma Holdings
XERS
$1.41B
| $43.3K | ﹤0.01% |
+15,196
| New | +$39K |
|
2486
Karyopharm Therapeutics
KPTI
$155M
| $42.8K | ﹤0.01% |
+3,436
| New | +$42.7K |
|
2487
ThredUp
TDUP
$741M
| $39.4K | ﹤0.01% |
46,762
+122
| +0.3% | +$149 |
|
2488
Sutro Biopharma
STRO
$385M
| $39.1K | ﹤0.01% |
+1,131
| New | +$44.3K |
|
|
OLPX
2489
DELISTED
Olaplex Holdings
OLPX
| $36.9K | ﹤0.01% |
15,713
+497
| +3% | +$1.01K |
|
2490
Banco Bradesco
BBD
$38.4B
| $36.9K | ﹤0.01% |
13,868
-365
| -3% | -$935 |
|
2491
Lexicon Pharmaceuticals
LXRX
$982M
| $35.3K | ﹤0.01% |
22,512
| – | – |
|
2492
FuboTV Inc
FUBO
$257M
| $35.3K | ﹤0.01% |
+2,073
| New | +$37.4K |
|
2493
Caribou Biosciences
CRBU
$151M
| $34.5K | ﹤0.01% |
17,615
+6,209
| +54% | +$12.7K |
|
|
ORGN
2494
DELISTED
Origin Materials
ORGN
| $32K | ﹤0.01% |
+693
| New | +$25.1K |
|
2495
W&T Offshore
WTI
$484M
| $28.2K | ﹤0.01% |
+13,128
| New | +$29.2K |
|
2496
Fractyl Health
GUTS
$121M
| $27.8K | ﹤0.01% |
+11,000
| New | +$35.9K |
|
|
TELL
2497
DELISTED
Tellurian Inc.
TELL
| $26.9K | ﹤0.01% |
27,786
-3,486
| -11% | -$3.01K |
|
2498
Solid Power
SLDP
$459M
| $26.2K | ﹤0.01% |
19,393
+3,925
| +25% | +$6.21K |
|
2499
Entravision Communication
EVC
$984M
| $23.7K | ﹤0.01% |
+11,451
| New | +$22.9K |
|
|
DADA
2500
DELISTED
Dada Nexus
DADA
| $21.7K | ﹤0.01% |
11,422
| – | – |
|
Similar funds
Cerity Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Cerity Partners held 2,621 positions worth $45.2B, up 19% from $38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Cerity Partners deployed $5.18B of net new capital in Q3 2024, opening 399 new positions and adding to 1,662 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,234,812 shares worth $1.18B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $64M trimmed.
- Cerity Partners's largest Q3 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,234,812 shares worth $1.18B.
- Cerity Partners added most to Apple in Q3 2024, an estimated $250M increase.
- Cerity Partners's biggest Q3 2024 reduction was Vanguard Total Stock Market ETF, cutting an estimated $64M.
- Cerity Partners fully exited AssetMark Financial Holdings, Inc. in Q3 2024, selling an estimated $20.9M.
- Cerity Partners's ten largest holdings make up 25% of its $45.2B portfolio in Q3 2024.
- Cerity Partners opened 399 new positions and closed 95 in Q3 2024.
- Cerity Partners's portfolio value rose 19% quarter-over-quarter to $45.2B.
Based on Cerity Partners's 13F filing for Q3 2024, filed 12 Nov 2024.